Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novavax concludes subject enrolment in Covid-19 vaccine trial

pharmaceutical-technologyFebruary 23, 2021

Tag: COVID-19 vaccine , NVX-CoV2373 , Novavax , Matrix-M

PharmaSources Customer Service